IgE-mediated bleomycin hypersensitivity: Evidence from drug-reactive T lymphocytes

Cytometry B Clin Cytom. 2023 Nov;104(6):471-473. doi: 10.1002/cyto.b.22146. Epub 2023 Nov 15.

Authors

Didier Ebo^{1

2

3}, Michiel Beyens^{1

2}, Alessandro Toscano^{1

2}, Christel Mertens¹, Jessy Elst¹, Vito Sabato^{1

2}

Affiliations

¹ Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
² Immunology, Allergology, Rheumatology, Antwerp University Hospital, Antwerp, Belgium.
³ Departement of Immunology and Allergology, AZ Jan Palfijn, Ghent, Belgium.

PMID: 37964629
DOI: 10.1002/cyto.b.22146

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bleomycin / adverse effects
Drug Hypersensitivity* / diagnosis
Flow Cytometry
Humans
Hypersensitivity*
Immunoglobulin E
T-Lymphocytes

Substances

Immunoglobulin E
Bleomycin

Grants and funding